2m 2m 2m 2m 2m 2m 2m
Madrigal Pharmct (MDGL)
NASDAQ
$450.83-$2.51 (-0.55%)
Price as of Oct 22, 2026 7:30 PM EDT- $10.6BMarket Cap
- 10.10%1-Year Change
- BiotechnologyIndustry
Madrigal Pharmct (MDGL)
$450.83-$2.51 (-0.55%)
MDGL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $453.34 | ||
Change | -$9.58 (-2.05%) | ||
Open | $458.11 | ||
High | $462.50 | ||
Low | $452.08 | ||
Previous Close | $457.96 | ||
Volume | 212,689 | ||
30-Day Average Volume | 292,111 | ||
1-Week Change | -0.45% | ||
1-Month Change | -12.26% | ||
1-Year Change | 10.10% | ||
3-Year Change | 248.15% | ||
5-Year Change | 491.60% | ||
Fundamentals | |||
Shares Outstanding | 23.1M | ||
Total Assets | $1.2B | ||
Market Cap | $10.6B | ||
Enterprise Value | $10.6B | ||
Period: QTR TTM FY | |||
Revenue | $364.3M | ||
Net Income | -$57.9M | ||
Free Cash Flow | $19.1M | ||
EBIT | -$57.9M | ||
EBITDA | -$57.6M | ||
Net Working Capital | $825.0M | ||
EPS | -$1.99 | ||
Enterprise Value/EBITDA | -185 | ||
Enterprise Value/Revenue | 29 | ||
P/B | 20 | ||
P/E | -230 | ||
PEG | -6 | ||
Price/Free Cash Flow | 555 | ||
Price/Operating Cash Flow | 454 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 35 | ||
Last Split Date | 07/25/2016 | ||
Earnings & Revenue